- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03092609
Neuroplasticity in an Extended Amygdala Network as a Target Mechanism for Attention Bias Modification Outcome
January 11, 2022 updated by: Northern Michigan University
Anxiety disorders are one of the most common psychological disorders.
Underlying anxiety is an increased attentional bias to threat, which has been identified as a causal contributor in the development of anxiety.
Given this causal relationship, attention bias modification was introduced as a treatment option where anxiety is reduced by training individuals to direct their attention away from threat and thereby decreasing anxiety.
Over a decade of research using this approach, called attention bias modification (ABM), suggests that overall the approach is effective in reducing anxiety.
Although ABM appears to be a very promising treatment option for anxiety, there are several factors limiting the effectiveness of ABM.
These include the recognition of individual-level needs and a known underlying mechanism of action by which ABM is effective.
Neuroimaging evidence suggests that attentional bias to visual threat is associated with a network of brain regions including the amygdala, anterior cingulate cortex, and visual cortex.
In human participants, experience-dependent neuroplasticity is visible in voxel-based morphometry based measures of gray matter volume following training.
Recently, voxel-based morphometry measures of gray matter volume have been linked to dendritic spine density-a known cellular mechanism for learning-related neuroplasticity.
Thus, voxel-based morphometry measures are ideally suited to measure learning-related neuroplasticity following attention bias modification.
In this proposal participants' level of attentional bias, anxiety, and gray matter volume will be measured before and after completing six weeks of attention bias modification training (N = 50) or attention control training (N= 50).
The proposal aims to (1) establish that pre-treatment bias predicts variability in gray matter volume in the extended amygdala and anterior cingulate cortex, (2) assess the extent to which reduced extended amygdala and anterior cingulate cortex gray matter volume following ABM underlies reductions in attentional bias and anxiety, and (3) Establish pre-treatment bias as a predictor of successful ABM as measured by reduced bias, reduced anxiety, and reduced gray matter volume in the extended amygdala and anterior cingulate cortex.
Consistent with the objectives of the AREA grant and NIMH's focus on identifying and validating new targets for treatment development that underlie disease mechanisms, the current proposal plans to involve students at a rural primarily undergraduate university in a research project aimed at establishing neuroplasticity in the extended amygdala and anterior cingulate cortex as a target mechanism for ABM training outcome, which could be used to objectively track training-related outcomes in anxiety treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
119
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Marquette, Michigan, United States, 49855
- Northern Michigan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 37 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Handedness (right handed)
- Normal Vision
- High Anxiety
- Preexisting Attentional Bias
Exclusion Criteria:
- No MRI contraindications
- No History of Head Injury
- No Neurological History
- Psychological History
- Limited Recreational Drug Use, No Abuse
- Limited Prescription Drug Use, No Abuse
- No Claustrophobia
- Not Pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Attention Bias Modification
|
Attention bias modification (ABM) sessions will consist of a modified dot-probe task that only contains incongruent trials (i.e., target-dot - neutral stimulus 100% pairing).
|
|
Active Comparator: Attention Control
|
Attention control (AC) sessions, will consist of a standard dot-probe task (i.e., target-dot - neutral/threat stimulus 50% pairing).
Thus, for AC participants, bias should remain the same, while ABM participants should show a reduced bias to threat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attentional Bias
Time Frame: Baseline and after 6 weeks of the intervention
|
Reaction time difference to congruent and incongruent trials in the dot-probe task, which measure heightened attentional bias to threat.
|
Baseline and after 6 weeks of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State and Trait Anxiety
Time Frame: Baseline and after 6 weeks of the intervention
|
Anxiety as measured by the Speilberger State-Trait Anxiety Inventory
|
Baseline and after 6 weeks of the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MRI measures of gray matter volume
Time Frame: Baseline and after 6 weeks of the intervention
|
T1-weighted MRI measures of gray matter volume
|
Baseline and after 6 weeks of the intervention
|
|
MRI measures of structural and functional connectivity
Time Frame: Baseline and after 6 weeks of the intervention
|
Diffusion-tensor weighted MRI based measures of structural connectivity and functional MRI based measures of functional connectivity.
|
Baseline and after 6 weeks of the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Joshua M Carlson, PhD, Northern Michigan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Carlson JM, Fang L, Koster EHW, Andrzejewski JA, Gilbertson H, Elwell KA, Zuidema TR. Neuroplastic changes in anterior cingulate cortex gray matter volume and functional connectivity following attention bias modification in high trait anxious individuals. Biol Psychol. 2022 Jul;172:108353. doi: 10.1016/j.biopsycho.2022.108353. Epub 2022 May 13.
- Carlson JM, Fang L. Attentional bias to threat and gray matter volume morphology in high anxious individuals. Cogn Affect Behav Neurosci. 2022 Jun;22(3):600-609. doi: 10.3758/s13415-021-00968-9. Epub 2021 Nov 9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2017
Primary Completion (Actual)
March 14, 2020
Study Completion (Actual)
March 14, 2020
Study Registration Dates
First Submitted
March 14, 2017
First Submitted That Met QC Criteria
March 21, 2017
First Posted (Actual)
March 28, 2017
Study Record Updates
Last Update Posted (Actual)
January 12, 2022
Last Update Submitted That Met QC Criteria
January 11, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HS13-555
- R15MH110951 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Data will be uploaded to the NIMH Data Archive
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on Attention Bias Modification
-
University of Texas at AustinArcade TherapeuticsRecruiting
-
University of OsloDiakonhjemmet Hospital; University of Oxford; ExtrastiftelsenCompletedMajor Depressive DisorderNorway
-
University of OsloDiakonhjemmet Hospital; University of Oxford; Sorlandet Hospital HFCompleted
-
University of Texas at TylerPsi Chi; Sarah Sass, PhDActive, not recruiting
-
Florida State UniversitySan Diego State UniversityCompleted
-
Hunan Normal UniversityCompletedDepressive Disorder, MajorChina
-
University of Nebraska LincolnCompletedPosttraumatic Stress DisorderUnited States
-
Humboldt-Universität zu BerlinCompletedObsessive-Compulsive DisorderGermany
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Umeå UniversityCompleted